FDA Inspection 1299522 — Island Kinetics, Inc. d.b.a. CoValence Laboratories

Island Kinetics, Inc. d.b.a. CoValence Laboratories — FEI 3002408934

The FDA completed an inspection of Island Kinetics, Inc. d.b.a. CoValence Laboratories on January 23, 2026 in Chandler, AZ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 23, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chandler, AZ (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
136121 CFR 211.100(a)Absence of Written Procedures
202721 CFR 211.192Investigations of discrepancies, failures